Gel Stent Market Size, Share, Industry Analysis, Trends, Growth, Forecasts, 2032

Gel Stent Market

Gel Stent Market - By Clinical Trials (Preclinical, Clinical Phase I/Ii, Clinical Phase Iii, Research, Clinical Phase I, And Clinical Phase Ii), By End User (Eye Research Institutes, Eye Clinics, And Hospitals), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 – 2032

Category: Medical Device Report Format : PDF Report Code: ZMR-1923 Status : Upcoming
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1.37 Billion USD 3.81 Billion 12.03% 2023

Description

Gel Stent Industry Prospective:

The global gel stent market size was worth around USD 1.37 billion in 2023 and is predicted to grow to around USD 3.81 billion by 2032 with a compound annual growth rate (CAGR) of roughly 12.03% between 2024 and 2032.

Global Gel Stent Market 2032Request Free Sample

The report analyzes the global gel stent market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the gel stent industry. 

Global Gel Stent Market: Overview

For the treatment of the narrowed arteries, a small, expandable tube is used; this small tube is known as a stent. To prevent the arteries from bursting and providing blood flow to the weak arteries the stents prove very helpful. Soft collagen-derived gelatin is used for the preparation of the gel stent. The stent gets hydrated and puffs up while injecting, which creates a flexible and soft channel that sticks to the ocular tissue and is not able to move. The procedure is minimally invasive.

Global Gel Stent Market: Growth Factors

One of the leading causes of blindness is glaucoma. Another factor is the population that above the age of 40 has more chances of contracting eye diseases and faulty eye structures. The increase in the geriatric population and the above-stated reasons are the factors that are driving the growth of the global gel stent market. There are many cases of glaucoma being registered across the world thus fuelling the market growth. The factors that will fuel the market growth in the coming years are a rise in healthcare expenditure, developments in technologically advanced procedures, an increase in the cases of glaucoma, and increasing demand for minimally invasive procedures. Some factors will restrain the market growth such as lack of availability of professionals that have good knowledge and the increased cost of the procedure. The absence of knowledge and experience regarding the technique, efficacy, and complication that are included in the gel stent are the other factors that will affect the gel stent market negatively.

Gel Stent MarketRequest Free Sample

Global Gel Stent Market: Restraints

The global market for gel stents is confronted with several obstacles that prevent its growth from being unrestricted. There is a substantial obstacle in the form of the demanding regulatory approval procedure for medical devices, which includes gel stents. This approach frequently results in a protracted time-to-market and increased development expenses. Furthermore, the high initial cost that is connected with the production and adoption of gel stents is a barrier that exists, which restricts the accessibility of gel stents for patients in particular regions and may potentially inhibit the universal acceptance of gel stents.

Furthermore, the absence of long-term clinical data on the efficacy and safety of gel stents may be a contributing factor to the reluctance of both physicians and patients, which in turn may hinder the expansion of the market. In addition, the market dynamics are made more complicated by the presence of competition from alternative glaucoma treatment choices and surgical procedures. As a result, manufacturers of gel stents are required to negotiate a competitive environment. When taken as a whole, these constraints highlight the necessity of adopting strategic ways to address regulatory obstacles, cost restrictions, and evidence-based issues to ensure the continued expansion of the worldwide gel stent market with sustained growth.

Global Gel Stent Market: Report Scope

Report Attributes Report Details
Report Name Gel Stent Market Research Report
Market Size in 2023 USD 1.37 Billion
Market Forecast in 2032 USD 3.81 Billion
Growth Rate CAGR of 12.03%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered AqueSys, Inc. and ALLERGAN, and others.
Segments Covered By Clinical Trials, By End-User, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Gel Stent Market: Challenges

There are several obstacles that the worldwide gel stent market must overcome, which affect the industry's expansion and broad adoption. However, one of the most significant hurdles is the complex nature of the surgical procedures that are involved in gel stent insertion. These operations require ophthalmic surgeons to possess specialized expertise and undergo extensive training. This presents a challenge to the seamless incorporation of gel stents into ordinary clinical practices, as the steep learning curve for surgeons may delay the acceptance of this technique among a wider population. The market also confronts problems related to reimbursement policies and coverage, since the economic feasibility of gel stent treatments may be a concern for both healthcare providers and patients.

In addition, the market faces challenges connected to reimbursement policies. The market dynamics are further complicated by the ever-changing landscape of glaucoma treatment alternatives and the requirement for long-term clinical data. This creates a tough environment for producers to establish the safety and efficacy of gel stents. To address these issues, stakeholders will need to work together to improve training programs, traverse the complexities of reimbursement, and provide rigorous clinical data. This will allow gel stents to be established as a viable and sustainable solution in the field of glaucoma therapy.

Global Gel Stent Market: Segmentation

The market for gel stents is globally fragmented into clinical trials and end users.

Depending on the clinical trials, the global market is segregated into preclinical, clinical phase I/II, clinical phase III, Research, clinical phase I, and clinical phase II.

Depending on the end user, the market is categorized into eye research institutes, eye clinics, and hospitals.

Global Gel Stent Market: Regional Analysis

The global gel stent market is regionally diversified into Latin America, the Middle East & Africa, Western Europe, Eastern Europe, North America, and Asia Pacific. The highest market growth is registered by North America in terms of value and it is followed by Europe. The increase in awareness among consumers regarding the latest treatments and technologies, developing economies, and the increase in the number of cases of glaucoma are some of the factors that are contributing to the growth of the gel stent market. In the coming years, the market growth in the Asia Pacific region will experience a rapid improvement owing to the prevalence of glaucoma, the rising significance given to the development of novel technology, the developing economy, and others.

Global Gel Stent Market: Competitive Players

The key market players that are involved in the gel stent market include

  • AqueSys. Inc.
  • ALLERGAN.

The global gel stent market is segmented as follows:

By Clinical Trials

  • Preclinical
  • Clinical Phase I/Ii
  • Clinical Phase Iii
  • Research
  • Clinical Phase I
  • Clinical Phase Ii

By End User

  • Eye Research Institutes
  • Eye Clinics
  • Hospitals

Global Gel Stent Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provide

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, ongoing, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

Glaucoma, characterized by high intraocular pressure, is treated with gel stents. Gel stents are biocompatible, soft, and flexible implants. It drains extra eye fluid to lower intraocular pressure and protect the optic nerve. The gel stent is put minimally invasively to provide a more comfortable and less invasive alternative to glaucoma surgery.
 

One of the leading causes of blindness is glaucoma. Another factor is the population that is above the age of 40 has more chances of contracting eye diseases and faulty eye structures.

According to a study, the global gel stent market size was worth around USD 1.37 billion in 2023 and is predicted to grow to around USD 3.81 billion by 2032.

The CAGR value of the gel stent market is expected to be around 12.03% during 2024 - 2032.

The highest market growth is registered by North America in terms of value and it is followed by Europe.

The key market players that are involved in the gel stent market include AqueSys, Inc. and ALLERGAN.

The global gel stent market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed